Transpact Enterprises Limited

Equities

TRANSPACT

INE06YD01010

Advanced Medical Equipment & Technology

Market Closed - Bombay S.E. Other stock markets 11:00:57 04/07/2024 BST			5-day change	1st Jan Change
310 ^INR	+6.90%		+6.90%	-19.48%

05-30	Transpact Enterprises Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
03-14	Transpact Enterprises Limited Approves Appointment of Ms. Amrita Gupta as the Company Secretary and Compliance Officer	CI

Transpact Enterprises Limited Announces Unaudited Standalone Earnings Results for the Six Months Ended September 30, 2019

December 05, 2019 at 04:49 am

Transpact Enterprises Limited announced unaudited standalone earnings results for the six months ended September 30, 2019. For the six months, the company announced loss for the period of INR 3.883 million and loss per share, basic and diluted before and after extraordinary items of INR 10.51.

Latest news about Transpact Enterprises Limited

Transpact Enterprises Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-30	CI
Transpact Enterprises Limited Approves Appointment of Ms. Amrita Gupta as the Company Secretary and Compliance Officer	03-14	CI
Transpact Enterprises Limited Announces Resignation of Damini Baid as Woman Additional Independent Director	03-07	CI
Transpact Enterprises Limited Announces Resignation of Puneet Vaidya as Company Secretary	02-22	CI
Transpact Enterprises Limited Announces Board Changes	10/10/23	CI
Transpact Enterprises Limited Announces Resignation of Shariq Nisar from Non-Executive Independent Director	01/09/23	CI
Transpact Enterprises Limited Announces Cessation of Aslam Khan as Managing Director	01/09/23	CI
Transpact Enterprises Limited Announces Resignation of Aslam Khan from Board	01/09/23	CI
Transpact Enterprises Limited Announces Director Resignations	01/09/23	CI
Transpact Enterprises Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/05/23	CI
Transpact Enterprises Limited Appoints Puneet Vaidya as the Company Secretary and Compliance Officer	03/05/23	CI
Transpact Enterprises Limited Announces Resignation of Viraj Mane as Company Secretary and Compliance Officer	07/04/23	CI
Raman Talwar and Kaushik Waghela entered into a sale purchase agreement to acquire 32.2% stake in Transpact Enterprises Limited from Aslam Khan for INR 16.8 million.	23/03/23	CI
Raman Talwar and Kaushik Waghela made an offer to acquire 26% stake in Transpact Enterprises Limited for INR 14.1 million.	23/03/23	CI
77,500 Equity Shares of Transpact Enterprises Limited are subject to a Lock-Up Agreement Ending on 10-SEP-2022.	09/09/22	CI
Transpact Enterprises Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/05/22	CI
Transpact Enterprises Limited Reports Audited Financial Results for the Half Year and Financial Year Ended March 31, 2021	23/06/21	CI
Transpact Enterprises Limited Approves Appointment of Viraj Mane as Company Secretary	17/03/21	CI
Transpact Enterprises Limited Reports Earnings Results for the Half Year Ended September 30, 2020	14/11/20	CI
Transpact Enterprises Limited Announces Resignation of Kirti Didwania as Company Secretary	29/09/20	CI
205,230 Equity Shares of Transpact Enterprises Limited are subject to a Lock-Up Agreement Ending on 10-SEP-2020.	09/09/20	CI
Transpact Enterprises Limited Announces Audited Earnings Results for the Half Year and Year Ended March 31, 2020	31/07/20	CI
Transpact Enterprises Limited Announces Unaudited Standalone Earnings Results for the Six Months Ended September 30, 2019	05/12/19	CI
Transpact Enterprises Limited has completed an IPO in the amount of INR 13.52 million.	04/09/19	CI
Transpact Enterprises Limited has filed an IPO.	26/06/19	CI

Chart Transpact Enterprises Limited

Duration

Period

More charts

Company Profile

Transpact Enterprises Ltd is engaged in design, development, manufacturing, and distribution of therapeutic devices and rehabilitations services with analytics and management software system. The Companyâs products include Vestibulator Chair, Vestibulator and RehabSoft. Vestibulator Chair is an ergonomically designed compact vestibular therapy device for at home therapy of children suffering from vestibular dysfunction and developmental disorders. Vestibulator is a compact, mechanized, therapeutic healthcare device, which is ergonomically designed to provide stimulation for vestibular, neuro-developmental, and sensory integration therapy. RehabSoft is a cloud-based therapy and rehabilitation software solution developed to streamline and manage the therapy, rehab clinical documentation, nutrition schedule, administrative processes, and training and individual education plan.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
TRANSPACT ENTERPRISES LIMITED	-19.48%	1.34M
THERMO FISHER SCIENTIFIC	+0.91%	204B
DANAHER CORPORATION	+3.74%	178B
INTUITIVE SURGICAL, INC.	+28.89%	154B
BOSTON SCIENTIFIC CORPORATION	+31.66%	112B
SIEMENS HEALTHINEERS AG	+1.83%	64.16B
EDWARDS LIFESCIENCES CORPORATION	+19.45%	54.88B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.44%	46.69B
AGILENT TECHNOLOGIES, INC.	-9.28%	36.8B
GE HEALTHCARE TECHNOLOGIES INC.	-0.10%	35.26B

Other Advanced Medical Equipment & Technology